Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Wegovy
Biotech
Lilly's obesity pill maintains weight lost on injectable GLP-1s
Patients maintained most of their weight loss after switching from injectable GLP-1s, teeing Lilly up to target people taking Novo Nordisk’s Wegovy.
Nick Paul Taylor
Dec 18, 2025 8:20am
Vanda tackles Wegovy-driven vomiting, sparking race to ph. 3
Nov 18, 2025 10:44am
Fierce Pharma
Big Pharma bets big on MASH with a new combo playbook
Oct 17, 2025 9:30am
Novo pushes ahead with amylin after seeing ph. 3 tolerability
Sep 16, 2025 8:12am
Fierce Pharma
Novo charts major restructuring, layoffs under new CEO
Sep 10, 2025 8:41am
Fierce Pharma
Novo Nordisk names new CEO as it cuts sales, profit outlook
Jul 29, 2025 10:10am